Related Experiment Video
Updated: Jul 15, 2026
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
New antiretroviral agents.
Lawrence Siegel1, Roy M Gulick
1Division of International Medicine and Infectious Diseases, Weill Medical College of Cornell University, Box 566, 525 East 68th Street, New York, NY 10021, USA.
Current Infectious Disease Reports
|April 14, 2007
Summary
Newer antiretroviral drugs are in development to combat drug-resistant HIV and improve patient outcomes. These investigational compounds offer enhanced tolerability, convenience, and efficacy for HIV treatment.
Area of Science:
- Virology
- Infectious Diseases
- Pharmacology
Background:
- Significant progress has been made in HIV treatment with 22 approved antiretroviral drugs.
- There remains a critical need for novel antiretroviral agents with improved safety, tolerability, and activity against resistant strains.
Purpose of the Study:
- To review investigational antiretroviral compounds in clinical development.
- To highlight promising new agents for the treatment of HIV-infected individuals.
Main Methods:
- Review of current literature on antiretroviral drug development.
- Focus on compounds that have advanced to clinical trials.
Main Results:
- Development is ongoing for new agents in traditional antiretroviral classes.
- Novel mechanistic classes, including entry, integrase, and maturation inhibitors, are under investigation.
Conclusions:
- Investigational antiretroviral compounds show promise for advancing HIV therapy.
- Future HIV treatment may benefit from a broader range of drugs with diverse mechanisms of action.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
02:33Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:29Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...